Some six years after picking up Seattle’s Universal Cells for $102 million, Astellas Pharma is opening a second location for ...

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

2. Astellas unveils new Japan site for cell therapy research arm Universal Cells, transferring 12 roles overseas For its cell ...

In a trial in the US, for instance, a dozen patients with type 1 diabetes were injected with islets, created from donated ...

In June 2023, Peking University researchers successfully reversed type 1 diabetes in a patient, opening the possibility of a ...

Spinach, green tea, apples, celery, asparagus, coffee and berries are all good examples of foods high in polyphenols - which ...

Three patients are in “safe, deep remission” after receiving a CRISPR-Cas9-modified cell therapy for autoimmune disease ...

A pair of American scientists has been honored with the 2024 Nobel Prize in Medicine for their role in the groundbreaki ...

Despite higher levels of mRNA encoding SG proteins during pancreatic tumorigenesis, this study finds no SG formation in ...

The Japanese pharma said its wholly-owned subsidiary Universal Cells will work with Adaptimmune on a co-development and co-marketing agreement. The deal could be worth up to $897.5 million for ...

Dr. Theresa Gabana, in a lawsuit filed Tuesday in Suffolk Superior Court, alleges she was unjustly fired in December 2021 ...

Physicist Edoardo Baldini (left) and Sarah Everett, director of global impact and research at Tito’s Handmade Vodka, reveal ...